Stromal-derived factor 1 (SDF-1) and CXCR4 comprise a unique chemokine/chemokine receptor pair, exhibiting important functions in morphogenesis and growth regulation as well as attractant properties on T lymphocytes. No data are available on SDF-1 and CXCR4 in normal or pathological thyroid tissues.
CXCR4 and CD18 mRNA, which indicates CXCR4 expression by leukocytes.
To define the cellular source of SDF-1 and CXCR4 in thyroid tissue, we examined various thyroid-derived cells. Fibroblasts are the most potent producers of SDF-1, although thyrocytes also secrete SDF-1 in vitro. Leukocytes showed very weak SDF-1 mRNA levels and no secretion of the chemokine. Immunohistology confirmed and extended these results; SDF-1 expression was found in fibroblasts, but not or very weakly in CD45 ϩ leukocytes and thyrocytes. Only leukocytes were CXCR4 ϩ . As examined by flow cytometry, the number of CD3 ϩ T cells expressing CXCR4 is significantly higher in the thyroid than in peripheral blood.
SDF-1 seems to be involved in thyroid tissue homeostasis in thyroid adenoma, but not in the maintenance of lymphocytic infiltration in GD. (J Clin Endocrinol Metab 86: 3368 -3376, 2001) O RIGINALLY IDENTIFIED for its ability to activate and chemoattract immune cells, the stromal-derived factor 1 (SDF-1) chemokine also fits additional important functions such as regulatory properties in growth and morphogenesis (1) . SDF-1 and its unique receptor CXCR4 are in many respects different from other chemokine/chemokine receptor pairs. Human SDF-1␣ is almost identical to the murine homologue, differing in one amino acid residue only. This strong evolutionary conservation of the primary structure of SDF-1, which is uncommon for a chemokine, and the unique chromosomal localization on chromosome 10q11 of the SDF-1 gene (2) gave the first indications that SDF-1 exerts important physiological functions. Studies with genetic knockouts of both SDF-1 and CXCR4 have underscored their vital role during cardiogenesis, vasculogenesis, and leukopoiesis (3, 4) . It is noteworthy that the lethal phenotype caused by the genetic knockouts has not been observed for other chemokines and chemokine receptors.
The constitutive SDF-1 expression in all tissues, although at different levels, is consistent with the presence of a GC-rich sequence in the 5Ј-flanking region of the SDF-1 gene, as is often the case with housekeeping genes (2) . However, SDF-1 messenger ribonucleic acid (mRNA) was reduced or lost in colonic adenomas and in the majority of gastrointestinal tumors compared with that in normal adjacent tissues (5, 6) . Moreover, 27 malignant human cell lines of different origins were SDF-1 mRNA negative (5) . There are no other reports on SDF-1 expression in human adenomas and cell lines. SDF-1 and its receptor may be involved in the maintenance of the normal thyroid architecture. In this study we compared the expression of SDF-1 and CXCR4 in thyroid autonomous single adenomas with the corresponding normal, but quiescent, tissue.
Besides the major role of SDF-1 in the maintenance of tissue homeostasis, SDF-1 plays a critical role in lymphocytic circulation and immune surveillance in postnatal life. SDF-1 belongs to the CXC chemokine family. In contrast to the Glu-Leu-Arg (ELR) motif containing CXC chemokines, which are effective on neutrophils, SDF-1 chemoattracts rested T lymphocytes and monocytes, dendritic cells, and CD34 ϩ progenitor cells (7, 8) . CXCR4 is found on naive T cells and Th2 cells, monocytes/macrophages, as well as dendritic and endothelial cells (9, 10) . Thus, both SDF-1 and CXCR4 may be involved in the maintenance of leukocyte infiltrates in thyroids affected by Graves' disease (GD). Such thyroids showed a strong accumulation of T cells, monocytes, and B cells, which are responsible for the production of autoantibodies against thyroid peroxidase (TPO) and the TSH receptor (TSH-R) (11, 12) . Here, intrathyroidal SDF-1 and CXCR4 mRNA levels were correlated to the 1) levels of TPO and TSH-R antibodies and 2) intrathyroidal leukocyte accumulation.
Apart from the fact that no information is available on the expression of SDF-1 and its receptor in the thyroid under normal and pathological conditions, their cellular sources and regulation are unknown. Thus, thyroid-derived lymphocytes, fibroblasts, and thyrocytes were isolated and, in addition to five thyroid carcinoma cell lines, checked for their basal and stimulated capacity to express SDF-1 and CXCR4 in vitro at the mRNA and protein levels.
Subjects and Methods

Patients
GD and thyroid adenoma (TA) were diagnosed on the basis of clinical, biochemical, and immunological features as well as from scintiscans ( Table 1) . In all patients with unifocal TA thyroid scans, Tc 99m pertechnatate showed a single hot nodule and a low uptake in the rest of the thyroid. Antibodies against the TSH-R [TSH binding-inhibiting Ig (TBII)] and TPO were measured in serum obtained during the 2 weeks before operation with commercial RIA kits (Henning, Berlin, Germany). Thyroid samples were obtained during operation. Fat and connective tissue were removed immediately. The TA tissue was carefully separated into adenomatous and normal tissues. In all cases the presence of a capsule was checked. The samples were frozen and stored in liquid nitrogen until required. CD18 mRNA was quantified as a degree of leukocytic infiltration using competitive RT-PCR (see below). The correlations between SDF-1 and CXCR4 mRNA levels and serum anti-TPO and TBII levels as well as CD18 mRNA expression were calculated using Spearman's method. Differences in CXCR4 and SDF-1 mRNA levels between GD patients with no or low as well as high anti-TPO levels and in autonomous and normal tissues of TA patients were analyzed using the Mann-Whitney U test for unpaired samples.
Preparation of thyroid-derived cells
Thyroid-derived cells were prepared from three thyroids of patients with GD. Thyrocytes and lymphocytes were enriched after gradual enzymatic tissue digestion and cultured over a period of 16 h as previously described (12) . Thyrocytes were obtained from the adherent fraction by incubating the cell monolayer with PBS in the absence of Ca 2ϩ /Mg 2ϩ for 45 min (13) . Residual fibroblasts within the thyrocyte fraction were eliminated by incubating the thyrocytes with the fibroblast-specific monoclonal antibody FibAS01 and goat antimouse IgGDynabeads M450 (DynAl, Hamburg, Germany) (13) . Thyroid-derived lymphocytes were enriched from the nonadherent fraction by Ficoll density gradient centrifugation (14) . By culturing small pieces of thyroid tissue in DMEM (Life Technologies, Inc., Grand Island, NY) with 10% FCS, outgrowing fibroblasts were obtained, harvested, and used in the fifth to seventh passage. The purity of the isolated thyroid-derived cells was determined using the indirect immunofluorescence technique on a FACScan (Becton Dickinson and Co., Mountain View, CA) (12, 13) . The human C643, SW1736, and HTh74 anaplastic thyroid carcinoma lines were provided by Dr. N.-E. Heldin (University of Uppsala, Uppsala, Sweden). The original dedifferentiated 8505C papillary carcinoma line and the FTC-133 follicular carcinoma line were purchased from the German Collection of Microorganisms and Animal Cell Cultures. All cell lines were cultured in DMEM/10% FCS.
In vitro cultures
Cells (1 ϫ 10 5 /well) were cultured on 24-well plates for 24 h. The medium was aspirated and replaced with 500 L Opti-MEM (Life Technologies, Inc.) without FCS to eliminate its possible stimulation. The medium contained human interleukin-1␣ (IL-1␣; 10 U/mL; Sigma, Deisenhofen, Germany), tumor necrosis factor-␣ (TNF␣; 5 ng/mL; Sigma), Antibodies to the TSH receptor (TBII, TSH binding-inhibiting Ig; normal value, Յ10 U/ml) and thyroid peroxidase (anti-TPO; normal value, Յ130 U/mL) were determined in the serum of patients by means of commercial RIA kits. Leukocyte infiltration was quantified on thyroid tissue samples by competitive CD18 mRNA RT-PCR. ND, Not determined.
lipopolysaccharide Escherichia coli 055:B5 (100 ng/mL; Sigma), or 10 ng/mL phorbol 12-myristate 13-acetate (PMA; Sigma). For each stimulator, triplicate cultures were analyzed.
The maximum or plateau of SDF-1 mRNA or protein expression was determined with HTh74 thyroid carcinoma cells taken as a standard. The SDF-1 mRNA level reached a plateau after about 12 h and was then analyzed. The highest SDF-1 protein levels were measured after 48 h. After that, the protein level decreased, probably due to proteolytic degradation (data not shown). For lymphocytes, the SDF-1 mRNA and protein levels were examined after 6 and 12 h, as unstimulated cells died during this time, impeding a measurement of basal quantity any later. Lysis buffer (0.2 mL) from the QIAGEN total RNA isolation kit (Hilden, Germany) was added to each culture well; the contents of three wells were then pooled for each cell type and frozen in liquid nitrogen for further mRNA analysis. The protein levels of cultures obtained from separate experiments were presented as the mean Ϯ sem. The MannWhitney test was used to determine the statistically significant difference between basal and stimulated cells.
SDF-1 enzyme-linked immunosorbent assay (ELISA)
The supernatants from the cultures were removed, frozen, and assayed for SDF-1 by ELISA. SDF-1 exists in two isoforms. The SDF1␣ and SDF1␤ proteins diverge only by the presence of four additional amino acids at the carboxyl-terminal end in the ␤-isoform. Relevant differences between both isoforms concerning the binding affinity to CXCR4 or different distributions under normal and pathological conditions are not known. Thus, two ELISA systems, one for the ␣-isoform and one for the ␤-isoform, were performed. Briefly, ELISA plates were coated with 100 L/well antihuman SDF-1 capture antibody (clone 79018.111; all ELISA reagents from R & D Systems, Wiesbaden, Germany) at 2 g/mL overnight. All incubation steps were performed at room temperature. After each incubation step, the solution was aspirated, and the wells were washed three times with PBS/0.05% Tween 20. The plates were blocked with 300 L PBS/1% BSA, 5% sucrose, and 0.05% NaN 3 for 2 h. One hundred microliters of the undiluted cell culture supernatant or of the human recombinant SDF-1␣ or -␤ standard were added and incubated for 2 h. One hundred microliters of the biotinylated anti-SDF-1␣ or -␤ detection antibody were then incubated for 2 h. One hundred microliters of streptavidin-horseradish peroxidase were added to each well and incubated for 20 min. One hundred microliters of substrate solution were applied (tetramethylbenzidine) for 20 -30 min, and 50 L stop solution (1 mol/L H 2 SO 4 ) were added. The plates were measured within 30 min using a microreader set at 450 nm.
RNA isolation and complementary DNA (cDNA) synthesis
Total cellular RNA was isolated from thyroid tissue and cell cultures with the QIAGEN total RNA isolation kit in accordance with the manufacturer's instructions. Genomic DNA was digested with 0.02 U deoxyribonuclease/g RNA (Roche Molecular Biochemicals, Mannheim, Germany) at 25 C for 10 min. Five micrograms of total RNA were taken to synthesize cDNA, using a first-strand cDNA synthesis kit from Amersham Pharmacia Biotech (Freiburg, Germany) in a reaction volume of 15 L.
Semiquantitative competitive RT-PCR
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA was quantified in accordance with the published method (15) . To quantify human SDF-1, CXCR4, and CD18 cDNA, a rapid one-step method was introduced to synthesize an internal homologous competitor (16, 17) . For example, amplification of thyroid tissue cDNA with the SDF-1 sense and SDF-1 hybrid primer (Table 2 ) resulted in a 209-bp SDF-1 competitor. The competitor was purified from excess primers and deoxy-NTPs using the QIAquick Gel Extraction Kit (QIAGEN) and quantified. The competitors were stabilized at defined concentrations in the PCR tubes using the method devised by Kö hler et al. (18) .
Variations between different cDNA preparations were corrected. All samples were first adjusted to contain equal concentrations of GAPDH cDNA in a semiquantitative RT-PCR (17) . We then estimated SDF-1, CXCR4, and CD18 cDNA in the samples. cDNA samples were titrated into RT-PCR amplification solutions containing known copies of the competitor. Both the sample cDNA and the competitor were coamplified using the sense and antisense primers. Two products were generated; one was derived from the cDNA, and the other, smaller in size, was derived from the competitor. Based on the difference in length, the sample cDNA and competitor PCR products were resolved by gel electrophoresis. The sample cDNA and competitor were quantified by measuring the intensity of ethidium fluorescence with a cooled CCD 8-bit image sensor, and the data were analyzed using Phoretix 1 D Plus software (Phoretix International, Newcastle-upon-Tyne, UK). The target copies equation was used to determine the ratio of sample cDNA copies per PCR to the number of competitor copies added, multiplied by the quotient of the cDNA signal, and divided by the competitor signal. Each 25-L amplification reaction contained 2.5 L 10-fold concentrated PCR buffer (15 mmol/L MgCl 2 ), 0.3 U Taq DNA polymerase (Roche Molecular Biochemicals), 100 mol/L deoxyNTPs, 0.1 mol/L of each primer, 1 L sample cDNA, and the stabilized competitor in adjusted dilutions.
CXCR4 receptor analysis in flow cytometry
To determine CXCR4 expression within the CD3 ϩ and CD3 Ϫ lymphocyte fractions, 2 ϫ 10 5 thyroid-derived or peripheral blood lymphocytes from the same patient (n ϭ 4) were stained with directly fluorochrome-labeled antibodies at the desired concentration for 25 min at 4 C (CXCR4-PE, CD3-Cy5, PharMingen Deutschland GmbH, Hamburg, Germany). The cells were washed three times with PBS/1% FCS and analyzed by flow cytometry in a FACScan (Becton Dickinson and Co.).
Immunohistology
SDF-1 expression was further examined on thyroid tissues by immunohistology. Briefly, cryostat sections (5 m thick) were fixed in 
Results
SDF-1, CXCR4 mRNA, and CD18 mRNA levels in thyroid tissues
All thyroid tissues investigated were SDF-1 and CXCR4 mRNA positive (Fig. 1) . The SDF-1 mRNA levels did not correlate with leukocyte infiltration, as determined by CD18 mRNA quantitation. The SDF-1 mRNA levels differed significantly between autonomous single adenomas and the corresponding normal tissue (P Ͻ 0.005) in TA patients. The SDF-1 mRNA levels in autonomous single adenomas were also significantly lower than those in GD tissues (P Ͻ 0.05), whereas the normal tissue from TA patients and GD tissues expressed nearly the same level of SDF-1 mRNA. Only 1 of 11 TA patients showed a higher SDF-1 mRNA level in the nodule compared with the normal tissue. In GD, TPO and anti-TBII antibody levels did not correlate with the SDF-1 mRNA level. We found a strong correlation between the CXCR4 and CD18 mRNA levels in GD tissues (r ϭ 0.9; P Ͻ 0.0001). CXCR4 mRNA levels further correlated with anti-TPO (r ϭ 0.81; P Ͻ 0.001), but not with the TBII (r ϭ 0.41; P ϭ 0.04) antibody levels. CXCR4 mRNA levels did not differ in FIG. 1 . Quantitation of SDF-1, CXCR4, and CD18 mRNA in the thyroid. SDF-1 (A) and CXCR4 (B) mRNA levels in the tissue of patients with TA (autonomous single nodules and normal tissue; n ϭ 11) and GD showing none or low (Յ200 U/mL; n ϭ 8) and high (Ն4000 U/mL; n ϭ 8) levels of anti-TPO antibodies in serum. C, Correlation between CXCR4 and CD18 mRNA levels in tissues affected by GD (n ϭ 16).
autonomous nodules and their corresponding quiescent tissue.
SDF-1 mRNA and protein expression
To define the cellular source of SDF-1 mRNA, we investigated isolated thyroid-derived cell populations. Determination of SDF-1␣ and SDF-1␤ in parallel revealed a higher expression of the SDF-1␣ in all SDF-1-positive cell types.
Fibroblasts expressed a higher basal SDF-1 mRNA level than thyrocytes. Both cell types secreted SDF-1 under basal conditions (Figs. 2 and 3) . PMA decreased SDF-1 mRNA and protein only in fibroblasts, but caused a dramatic increase in thyrocytes. IL-1 and TNF␣ did not stimulate SDF-1␣ secretion significantly. Thyroid-derived lymphocytes showed weak SDF-1 mRNA expression, but no basal SDF-1 secretion. Only lipopolysaccharide stimulated SDF-1 secretion, indicating the presence of CD14 ϩ monocytes/macrophages within the leukocyte fraction (data not shown).
We further investigated five thyroid-derived carcinoma cell lines. Two of them, 8505C and C643, showed only a faint SDF-1 mRNA signal and did not secrete the protein under basal conditions. Unstimulated HTh74 and FTC-133 showed SDF-1 mRNA expression (50 and 120 ϫ 10 Ϫ20 mol SDF-1 cDNA/PCR) and low SDF-1␣ secretion (data not shown). SW1736 cells expressed high basal SDF-1 (925 ϫ 10 Ϫ20 mol SDF-1 cDNA/PCR) mRNA and protein under basal conditions (Fig. 4) . PMA decreased SDF-1 mRNA and protein in the cell lines significantly.
Immunohistological detection of SDF-1
Immunostaining of serial thyroid tissue sections partly confirmed the results obtained from isolated intrathyroidal cell populations. SDF-1 was localized in stromal cells that were negative for the leukocyte common antigen (CD45). Thus, fibroblasts expressed SDF-1 (Fig. 5A) . Preincubation of the anti-SDF-1 antibody with SDF-1␣ completely abolished immunostaining (Fig. 5B) . The epithelial cells in all thyroid specimens examined, with a few exceptions, were completely SDF-1 negative. In contrast, cultured thyrocytes secreted SDF-1. CD45
ϩ leukocytes failed to express SDF-1; although in GD, some leukocytes within areas with high leukocytic infiltration were slightly positive for the chemokine (Fig. 5, C and D) . Additionally, SDF-1 was uniformly present in endothelial cells of varying blood vessel types (data not shown).
Expression of CXCR4
Thyroid-derived lymphocytes expressed CXCR4 mRNA (n ϭ 3; mean Ϯ sem; 5.6 Ϯ 0.7 ϫ 10 Ϫ18 CXCR4 cDNA/PCR; Fig. 6 ). Thyrocytes (1.3 Ϯ 0.2 ϫ 10 Ϫ20 CXCR4 cDNA/PCR) and fibroblasts (2.5 Ϯ 0.5 ϫ 10 Ϫ20 CXCR4 cDNA/PCR) showed a CXCR4 mRNA signal more than 500 times lower than that of thyroid-derived lymphocytes, mainly due to contamination by a few lymphocytes. Among the cell lines, only 8505C cells were CXCR4 mRNA positive (14.1 Ϯ 0.2 ϫ 10 Ϫ20 CXCR4 cDNA/ PCR; Fig. 6 ). These results correlated well with the data obtained by flow cytometry. Fibroblasts, thyrocytes, as well as most of the cell lines did not express CXCR4. CXCR4 was found on the surface of roughly a fourth of 8505C cells (data not shown). Double labeling CXCR4 and CD3 as a marker for T cells on peripheral blood and thyroid-derived lymphocytes from the Defined concentrations of the SDF-1 competitor were coamplified with identical GAPDH-adjusted sample cDNA aliquots in the same PCR tube. The sample cDNA and competitor PCR products were separated by gel electrophoresis. The target copies equation was used to determine the ratio of sample cDNA copies per PCR to the number of competitor copies added, multiplied by the quotient of the cDNA signal, and divided by the competitor signal. The original gel electrophoresis results are shown in the lower part of the figure. The concentration of the competitor is indicated above the gel electrophoresis. SDF-1␣ (B) and SDF-1␤ (C) were determined by ELISA (n ϭ 3). *, Significant differences between basal and stimulated SDF-1 levels, P Ͻ 0.05. same patients (Fig. 7) revealed that the number of CXCR4 ϩ T cells in the thyroid was significantly higher (CXCR4 ϩ within CD3 ϩ , mean Ϯ sem, 92.0 Ϯ 3.2%) than the number in the peripheral blood (CXCR4 ϩ within CD3 ϩ , 60.8 Ϯ 6.0%; P Ͻ 0.01).
Discussion
Autonomous nodules contained significantly lower SDF-1 mRNA levels compared with the corresponding normal tissue of the same patient. The difference is not due to variable leukocytic infiltration between the two tissue sites. This fact raises a question about the function of SDF-1 in normal and pathological thyroid tissue.
Lost or reduced expression of SDF-1 has been described in colonic adenomas and in hepatocellular, colon, esophageal, and gastric cancers (5, 6) . The researchers suggest a role for SDF-1 in the initiation or progression of benign and malignant tumors. However, it is unlikely that the degree of SDF-1 mRNA loss indicates the malignant potential, as no correlation between them has been found. Reduction of SDF-1 mRNA expression probably occurs early in the adenomacarcinoma sequence in colon carcinogenesis. Thus, SDF-1 may be a factor that is highly expressed in normal tissues to maintain normal architecture. As pointed out by Baggiolini (19) , the chemoattractant properties of SDF-1 are useful dur- ing morphogenesis to keep similar cells together and to provide tissue homeostasis. It is unclear whether this SDF-1 mRNA reduction in thyroid adenomas is the result or the cause of the development of a new tissue organization while still maintaining follicles as the normal thyroid gland does. Autonomous thyroid nodules are characterized by increased epithelial proliferation independent of their histopathological or molecular characteristics compared with both the tissue surrounding the nodule and normal thyroid tissue (20, 21) . Based on our finding that fibroblasts are the main producers of SDF-1 in the thyroid, a lower amount of stromal cells may be the cause of lower SDF-1 expression in autonomous nodules compared with that in the related normal thyroid.
SDF-1 possesses the highest capacity among chemokines to promote the attraction and arrest of circulating T lymphocytes on the luminal side of vascular endothelium for their recruitment into normal tissues (22) . Moreover, SDF-1 may have a concentration-dependent bifunctional effect on T cell migration, attracting at one concentration and repulsing at another, as recently reported (23) . Current results obtained in rheumatoid arthritis strongly imply that the interaction between SDF-1 and CXCR4 plays an important role in T cell accumulation in the inflamed synovium (24) . SDF-1 may present a specific T cell-recruiting function during the onset, but not in the later course, of GD. To clarify this question, fine needle biopsies of thyroid tissue would be useful. However, there is no indication for thyroid biopsy material from GD patients. The function of SDF-1 in the thyroid may go beyond the regulation of leukocyte migration, as we found no correlation between the SDF-1 mRNA level and leukocyte infiltration in GD tissues where marked differences in CD18 mRNA expression were evident. Leukocyte infiltrates are not only maintained by continued attraction from the peripheral blood, but also by proliferation in the thyroid (25) . However, SDF-1 is not involved in T cell proliferation, as it is unable to support IL-2 production and T cell proliferation either alone or in combination with coactivators, although SDF-1 can couple to distinct pathways that mediate cell survival, growth, and transcriptional activation.
The difference in SDF-1 mRNA levels in GD tissues with low or high leukocyte infiltration contrasts with our recently published results on RANTES, a CC chemokine that chemoattracts mainly CD45R0
ϩ T memory cells and monocytes (26) . Thyroid tissue of GD patients with high lymphocytic infiltration showed significantly higher RANTES mRNA levels than those with low infiltration. SDF-1 and RANTES were produced by different cellular sources. Only thyroid-derived lymphocytes were identified as potential producers of RANTES in the thyroid, whereas in the case of SDF-1, lymphocytes seemed the only cell population without or low SDF-1 production, as determined in vitro and by immunohistology. In situ, thyrocytes expressed SDF-1 at very low density or were SDF-1 negative, although the chemokine is strongly induced during in vitro culture. In accordance with the thyrocyte results, we found variable expression of SDF-1 in thyroid carcinoma cell lines. Four of five cell lines contained no, low, or moderate SDF-1 mRNA, supporting the study by Begum et al. (5) , who reported that in Northern blots SDF-1 mRNA is absent from 27 human different malignant cell lines. However, unstimulated SW1736 thyroid carcinoma cells secreted even higher SDF-1 amounts than fibroblasts.
All thyroid tissues were SDF-1 mRNA positive, which was caused by basal SDF-1 expression in thyrocytes and fibroblasts. This supports known data on an the constitutive presence of SDF-1 in a wide range of tissues. Most of the secreted SDF-1 is of the ␣-and not ␤-isoform, as shown by different ELISA systems. The missing correlation between the basal mRNA and protein levels in fibroblasts and thyrocytes is an unexpected result. Fibroblasts showed a high SDF-1 mRNA level and moderate SDF-1 secretion, which were confirmed by immunohistology. The basal SDF-1 mRNA level in thyrocytes was 10-to 100-fold lower, but they secreted equal amounts of SDF-1. This discrepancy may be based on different posttranscriptional regulation mechanisms in both cell types. IL-1 and TNF␣, proinflammatory cytokines that have been shown to be expressed in the thyroid, did not significantly increase SDF-1␣ expression in fibroblasts, thyrocytes, and the carcinoma cell lines. This represents a difference from most other chemokines, the production of which is strongly augmented by proinflammatory stimuli (27) . As known from other studies, PMA down-regulated SDF-1 in fibroblasts and carcinoma cell lines, but, surprisingly, upregulated SDF-1 in thyrocytes.
The distribution of CXCR4 in the thyroid completely differed from that of its ligand SDF-1. CXCR4 is present in thyroid-derived leukocytes. As shown in flow cytometry, CXCR4 is expressed at a higher number on thyroid-derived T-cells compared with peripheral T cells of the same patient. Recently, CXCR4 was shown to be expressed at significantly higher amounts in total CD45RA ϩ naive cells compared with CD45R0 ϩ memory cells in the peripheral blood. However, in the thyroid, the higher amount of CD45R0 ϩ memory cells is coupled with a higher amount of CXCR4 ϩ cells. This result agrees with the study by Nanki et al. (24) , who found that CXCR4 was markedly up-regulated on CD4 ϩ T cells from synovial tissue compared with that expressed by peripheral CD4 ϩ T cells. Peripheral T cells expressing CXCR4 may be selected for migration into the thyroid, or CXCR4 may be up-regulated during and/or after migration into the thyroid. PMA decreased CXCR4 on thyroid-derived lymphocytes, which is probably caused by receptor internalization (28) . As shown by flow cytometry, thyrocytes do not carry CXCR4, although other epithelial cells, such as intestinal and type II alveolar cells, reportedly expressed CXCR4 and thus may serve as targets for chemokine signaling (29 -31) . Intestine, as well as lung epithelial cells carrying CXCR4, are particularly important, as they comprise an interface between the body and the environment. These epithelial cells must have the capacity to generate strong inflammatory responses to provide prompt leukocyte attraction for clearance of offending agents. CXCR4 expression does not seem so important for thyroid epithelial cells.
Taken together, SDF-1 seems to be involved in normal thyroid tissue homeostasis, but not in the maintenance of leukocyte infiltration. To further address the role of SDF-1 in the thyroid, the following experiments may be useful: calcium mobilization assay in response to SDF-1 stimulation on thyroid-derived cells, SDF-1-stimulated migration assay with peripheral and thyroid-derived T cells as well as thyrocytes, and measuring the influence of SDF-1 on activationinduced apoptosis in peripheral and thyroid-derived T cells. 
